Mr Serwind Osgood Bancks Netzler, | |
1001 Mountain St, Suite 3-h, Carson City, NV 89703-3822 | |
(775) 445-7756 | |
(775) 841-0304 |
Full Name | Mr Serwind Osgood Bancks Netzler |
---|---|
Gender | Male |
Speciality | Counselor - Mental Health |
Location | 1001 Mountain St, Carson City, Nevada |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003946237 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Serwind Osgood Bancks Netzler, 1010 Silveranch Dr, Gardnerville, NV 89460-8684 Ph: (775) 513-9421 | Mr Serwind Osgood Bancks Netzler, 1001 Mountain St, Suite 3-h, Carson City, NV 89703-3822 Ph: (775) 445-7756 |
News Archive
Colon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to adapt to the lack of oxygen and nutrients inside the tumor. Statins, which are often prescribed to lower cholesterol, block this metabolic pathway and cause the cancer cells to die, as scientists from the German Cancer Research Center have now discovered.
A doctoral student at The University of Texas Health Science Center at Houston (UTHealth) has been awarded two research fellowships to study the spread of E. coli, a hard-to-treat bacterium that can lead to food poisoning.
Doctors at the University Heart Center in Hamburg, Germany successfully used transcatheter valve-in-valve implantation in elderly patients with degenerated bioprostheses in aortic and mitral position. This minimally invasive procedure was used as an alternative treatment option for patients who were at high surgical risk.
NicOx S.A. (NYSE Euronext Paris: COX) today announced that an important scientific article has been published in the September issue of the American Journal of Cardiology. The publication describes the blood pressure results from the 301 phase 3 study for naproxcinod in detail. Naproxcinod is the first-in-class Cyclooxygenase-Inhibiting Nitric Oxide Donating (CINOD) anti-inflammatory agent for the relief of the signs and symptoms of osteoarthritis (OA).
› Verified 4 days ago
Dr. Patricia A. Davin, PH.D. Counselor Medicare: Not Enrolled in Medicare Practice Location: 504 N Division St, Carson City, NV 89703 Phone: 775-885-9020 Fax: 775-885-9031 | |
Miss Casey Heckman, Counselor Medicare: Not Enrolled in Medicare Practice Location: 502 E John St, Suite A, Carson City, NV 89706 Phone: 775-883-9800 Fax: 775-883-9803 | |
Danielle Bennett, CACD-I Counselor Medicare: Not Enrolled in Medicare Practice Location: 1201 N Carson St, Carson City, NV 89701 Phone: 775-350-7250 | |
Ms. Desiree Lynne Misanko, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 1665 Old Hot Springs Rd Ste 150, Carson City, NV 89706 Phone: 775-687-0894 | |
Mariya Tkachenko, Counselor Medicare: Not Enrolled in Medicare Practice Location: 755 N Roop St Ste 101, Carson City, NV 89701 Phone: 775-841-6050 | |
Josee Ann Perrine, MFT LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2874 N Carson St, Ste 215, Carson City, NV 89706 Phone: 775-885-7717 Fax: 775-283-0231 |